Brokers Set Expectations for CRSP Q1 Earnings
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Brookline Capital Management issued their Q1 2025 earnings estimates for CRISPR Therapeutics in a research report issued on Tuesday, February 11th. Brookline Capital Management analyst L. Cann anticipates that the company will post earnings of ($0.74) per share for the quarter. The consensus estimate for CRISPR Therapeutics’ […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Brookline Capital Management issued their Q1 2025 earnings estimates for CRISPR Therapeutics in a research report issued on Tuesday, February 11th. Brookline Capital Management analyst L. Cann anticipates that the company will post earnings of ($0.74) per share for the quarter. The consensus estimate for CRISPR Therapeutics’ […]
